Compare SVRE & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SVRE | VVOS |
|---|---|---|
| Founded | 2014 | 2016 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9M | 2.6M |
| IPO Year | 2021 | 2020 |
| Metric | SVRE | VVOS |
|---|---|---|
| Price | $2.00 | $0.13 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.12 |
| AVG Volume (30 Days) | 55.4K | ★ 1.7M |
| Earning Date | 08-14-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 6.76 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $17,443,000.00 |
| Revenue This Year | $1,756.92 | $24.92 |
| Revenue Next Year | N/A | $56.44 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 16.05 |
| 52 Week Low | $0.55 | $0.13 |
| 52 Week High | $6.30 | $3.09 |
| Indicator | SVRE | VVOS |
|---|---|---|
| Relative Strength Index (RSI) | 52.79 | 32.30 |
| Support Level | $0.62 | $0.13 |
| Resistance Level | $1.96 | $0.55 |
| Average True Range (ATR) | 0.23 | 0.01 |
| MACD | 0.09 | 0.00 |
| Stochastic Oscillator | 80.93 | 11.97 |
Saverone 2014 Ltd is engaged in the design, development, and commercialization of transportation and safety solutions, designed to prevent car accidents based on its patented technology of detecting, analyzing, and locating cellular phone radio frequency, or RF signals. The company is developing two product lines: the first is an In-Cabin Driver Distraction Prevention Solution (known as SaverOne system), or DDPS; and the second is an Advanced Driver-Assistance System, or ADAS, product that detects vulnerable road users, or VRUs, and provides a warning to the vehicle regarding potential collision. Geographically, Saverone generates maximum revenue from Europe and the rest from Israel.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.